title: Further ex vivo evidence supporting higher aspirin dosing in patients with coronary artery disease and diabetes.
authors.forename: Kevin P
authors.initials: KP
authors.lastname: Bliden
authors.forename: Udaya S
authors.initials: US
authors.lastname: Tantry
authors.forename: Joseph
authors.initials: J
authors.lastname: DiChiara
authors.forename: Paul A
authors.initials: PA
authors.lastname: Gurbel
mesh_terms: D001241:Aspirin / Q000008:administration & dosage* / Q000494:pharmacology; D003324:Coronary Artery Disease / Q000097:blood / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications*; D003925:Diabetic Angiopathies / Q000097:blood / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*
chemical_list: D010975:Platelet Aggregation Inhibitors; D001241:Aspirin